Manifestations of Systemic Disorders Flashcards
Pyoderma gangrenosum
Characteristics?
Associated with chronic underlying inflammatory or malignant? 5
- Characteristics
- Rapidly evolving, idiopathic, chronic and severely debilitating ulcerative skin disease
Associated with chronic underlying inflammatory or malignant disease:
- Chronic Ulcerative colitis**
- Chronic active hepatitis
- Rheumatoid arthritis
- Crohn’s disease
- Hematologic malignancies
Pyoderma gangrenosum
- Hx? 3
- PE? 4
- Most common sites?3
- History:
- Acute onset with
- painful hemorrhagic pustule or painful nodule
- surrounded by erythematous halo. - PE:
- Breakdown with ulcer formation with dusky red or purple borders, -irregular and raised,
- boggy with perforations that drain pus. - Most common sites:
- Lower extremities,
- buttocks,
- abdomen
Pyoderma gangrenosum
Treatment?
- Treat underlying disease
- Avoid trauma
- High dose systemic (IV) corticosteroids****
- Systemic immunosuppression
Pyoderma gangrenosum: what kind of systemic immunosuppressants would we use? 3
- Sulfasalazine
- Cyclosporine
- Infliximab
Diabetic Associations
5
- Acanthosis nigricans
- Necrobosis lipoidica diabeticorum
- Granuloma annulare
- Thrush
- Intertrigo
Acanthosis nigricans
Characteristics? 2
Associated with what? 3
Characteristics:
- Velvety thickening and
- hyperpigmentation of the skin.***** (buzz words)
Associated with:
- Endocrine disorders
- Obesity
- Internal malignancy (will affect the mucous membranes more so than the other causes)
Which endocrine disorders are associated with Acanthosis nigricans? 2
What malignancies are most common?
- Diabetes
- Insulin resistant syndromes** (most commonly)
GI most common (will affect the mucous membranes more so than the other causes)
Acanthosis nigricans
Hx? 2
PE? 4
Most common sites? 4
History:
- Insidious onset;
- first visible change is darkening of pigmentation
PE:
- Hyperpigmentation,
- velvety looking,
- skin line accentuated,
- surface becomes wrinkled or creased.
Most common sites:
- Axilla,
- neck (back and sides),
- groin,
- antecubital fossae
Acanthosis nigricans
Rx?
3
- R/O Diabetes
- Treat associated disorder
- Usually none required
Necrobiosis Lipoidica (NL), Diabeticorum 1. 50% of pts with what have this?
- PE? 4
- Necrobiosis Lipoidica (NL), Diabeticorum Rx?
- Most common area?
- 50% of patients with NL are insulin dependent diabetics (longstanding Type I)
- PE:
- Oval, violaceous patch that expands slowly.
- Advancing border is red and the central area turns yellow-brown.
- Telangiectasias become prominent.
- Ulceration is possible esp. after trauma.
3. Difficult to treat, refer to derm
4. On the shin
Granuloma Annular
- Characteristics? 3
- SLight associated with what?
- Common in who?
- Hx? 1
- PE? 2
- Most common site?3
- Characteristics (arranged in a ring)
- Self limiting,
- asymptomatic,
- chronic dermatosis - Slight association with diabetes
- More common in older women
- History:
- Slowly increases over months, duration is variable - PE:
- Smooth, shiny firm ring of flesh colored papules and plaques (1 to 5cm)
- Annular with central depression - Most common site:
- dorsum of hands and feet,
- extremities, and
- trunk
Granuloma Annular
Treatment?
3
1. Treatment (not necessary) Disappears in 75% of pts in 2 years. If needed: 2. Potent topical steroids 3. Intralesional injections of steroids
Intertrigo Characteristics? 2
Related to what infections? 3
Associated with what disease? 3
Most common sites? 4
Dx?
- Irritation in the skin folds
- Worse with heat and moisture
Related to
- Candida,
- Fungus Irritation and
- Secondary bacterial infection (Group A & B strep, pseudomonas)
Associated with
- Diabetes,
- HIV,
- obesity
MOst common sites?
- Axilla,
- groins,
- gluteal folds,
- overlapping abdominal panniculus
Dx?
1. KOH smear
Intertrigo
PE? 4
Treatment?
3
What should be avoided?
PE:
- Erythema,
- or – pruritis,
- tenderness,
- erythematous plaques
Treatment: 1. Keep cool and dry (hairdryer) Treatment based on cause 2. Antifungal/antibacterial powders 3. Zinc oxide ointment reduces friction
- Topical steroids should be avoided
- What is Thrush?
- What do the lesions look like?
- Associations? 3
- Treatment? 3
- Yeast infection, usually candida.
- White plaques or red erosive areas in the oral mucosa
- Associations
- Diabetes
- HIV
- Immunosuppresion - Treatment
- Antifungal troches,
- fluconazole,
- itraconazole
Other systemic disorders that manifest dermatologic symptoms
4
- LUPUS
- DERMATOMYOSITIS
- SCLERODERMA
- XANTHOMA
LUPUS #1 Chronic cutaneous (discoid) 1. What will the lesions look like? 3 2. Progression to what is uncommon? 3. Treatment? 2
- Scarring,
- dispigmented,
- scaly plaques on face primarily.
- Progression to systemic lupus is uncommon
- Treatment with
- potent topical steroids
- +/- antimalarials (hydroxycholorquine)
Lupus #2 Subacute cutaneous 1. What population more common? 2. What are the skin lesions here? 3. 50% meet criteria for what? 4. Can be induced by what? 5. Treatment with what? 2
- White women age 15-40
- Polycyclic scaly plaques in sun exposed areas
- 50% meet criteria for systemic lupus.
- Can be drug induced
- Treatment with
- antimalarials or other
- immunosuppressants.
#3 Systemic lupus erythematosus (SLE) 1. What will the skin manifestations look like? 4
- Skin involvment in SLE in what %?
- Treatment? 2
3 Systemic lupus erythematosus (SLE)
- “Butterfly” facial erythema which is nonscarring
- Photosensitivity
- Oral ulcers
- Discoid lupus
- Skin involvement in 80% of SLE
- Treatment:
- antimalarials and
- immunosuppression
Dermatomyositis
Dermatitis characteristics? 5
Myositis characteristics? 2
Treatment? 2
What is present in the majority of these pts?
- Erythema,
- photosensitivity,
- heliotrope eyelid rash
- Gottron’s papules
- Calcinosis cutis (calcium deposits in the nails)
- Weakness of proximal muscles
- Elevation in muscle enzymes
- Steriods and methotrexate
- Malignancy
Where are Gottron’s papulse found?
3
- knuckles,
- periungual telangiectasia,
- poikiloderma (red, white, brown)
Scleroderma
Clinical presentation?
(CREST) 5
Treatment?
- Calcinosis (calcified lesions in hands)
- Reynaud’s phenomenon
- Esophageal dysmotility
- Sclerodactyly
- Telangiectasia
Treatment with systemic immunosuppressio
Progressive systemic sclerosis is what?
Treatment?
- Generalized sclerosis with internal organ involvement (heart, lungs, GI, kidney)
- Treatment with systemic immunosuppression
Xanthomas
- What are they?
- What do they look like? 2
- Associations? 4
- Common sites? 2
- Lipid deposits in skin and tendons.
- Yellow-brown, pinkish or orange
- macules, papules, plaques, nodules
Associations
- Hyperlipidemia
- Biliary cirrhosis,
- Diabetes,
- CRF
Common sites
- Upper and lower eyelids,
- inner canthus